News from NORD

Largest-Ever Study of Pemphigus and Pemphigoid Launched


 

A natural history registry that will provide a complete picture of each patient’s experience with pemphigus and pemphigoid has been launched by the International Pemphigus and Pemphigoid Foundation with NORD. This study will be open to patient worldwide to advance understanding and treatments for these rare conditions. The registry will be maintained on a platform developed by NORD in line with its mission to seek treatments or cures for all rare diseases. The project is supported by a cooperative agreement between NORD and the US Food and Drug Administration (FDA).

Recommended Reading

NORD Publishes Basic Principles for Health Coverage Reform
MDedge Cardiology
NORD Submits Letter to Congress on Pre-Existing Conditions
MDedge Cardiology
NORD Unveils “Do Your Share for Rare” Year-Long Awareness Campaign
MDedge Cardiology
Tickets Now On Sale for NORD’s 2017 Rare Impact Awards
MDedge Cardiology
FDA approves first home genetic health risk test
MDedge Cardiology
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Cardiology
NORD and Neurology Reviews Publish Special Report
MDedge Cardiology
Save the Date for the 2017 NORD Summit
MDedge Cardiology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Cardiology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Cardiology